Allianz Asset Management
PCRX icon

Allianz Asset Management’s Pacira BioSciences PCRX Stock Holding History

Allianz Asset Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-22,300
Closed -$554K – 2225
2025
Q1 		$554K Hold
22,300
– – ﹤0.01% 1846
2024
Q4 		$420K Buy
22,300
+5,600
+34% +$98.3K ﹤0.01% 1914
2024
Q3 		$251K Buy
+16,700
New +$286K ﹤0.01% 2031
2017
Q2 		– Sell
-21,100
Closed -$962K – 2669
2017
Q1 		$962K Buy
+21,100
New +$912K ﹤0.01% 2251
2016
Q4 		– Sell
-53,137
Closed -$1.82M – 2644
2016
Q3 		$1.82M Buy
+53,137
New +$2.08M ﹤0.01% 2022
2015
Q2 		– Sell
-214,773
Closed -$19.1M – 2474
2015
Q1 		$19.1M Sell
214,773
-54,479
-20% -$5.53M 0.02% 713
2014
Q4 		$23.9M Buy
269,252
+10,601
+4% +$1M 0.03% 637
2014
Q3 		$24.9M Buy
258,651
+88,656
+52% +$8.62M 0.03% 571
2014
Q2 		$15.6M Buy
169,995
+55,110
+48% +$4.2M 0.02% 636
2014
Q1 		$8.04M Buy
114,885
+17,572
+18% +$1.2M 0.01% 812
2013
Q4 		$5.59M Sell
97,313
-12,197
-11% -$641K 0.01% 912
2013
Q3 		$5.27M Sell
109,510
-135,890
-55% -$4.95M 0.01% 903
2013
Q2 		$7.12M Buy
+245,400
New +$7.1M 0.01% 751

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Allianz Asset Management's PCRX Position: Q2 2025 in Review

Allianz Asset Management sold out of Pacira BioSciences (PCRX) in Q2 2025, closing a stake of 22,300 shares — an estimated $554K sold.

Allianz Asset Management first reported a position in PCRX in Q2 2013 and held it in 13 quarters. The position peaked at $24.9M in Q3 2014. 233 funds tracked by Wall St. Rank hold PCRX as of Q2 2025.

  • Allianz Asset Management reported no remaining Pacira BioSciences position as of Q2 2025 after selling out during the quarter.
  • Allianz Asset Management sold 22,300 Pacira BioSciences shares in Q2 2025, an estimated $554K.
  • Allianz Asset Management first reported a position in Pacira BioSciences in Q2 2013 and held it in 13 quarters.
  • Allianz Asset Management's Pacira BioSciences position peaked at $24.9M in Q3 2014.
  • 233 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2025.

Based on Allianz Asset Management's 13F filing for Q2 2025, filed 28 Jul 2025.